Squamous Cell Carcinoma of Head and Neck (SCCHN)
3 clinical trials · Condition
◉ Watch Squamous Cell Carcinoma of Head and Neck (SCCHN)
| Record | Firm | Date |
|---|---|---|
| Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma (NCT07529873) | Groupe Oncologie Radiotherapie Tete et Cou | 2026-05-01 |
| A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors (NCT04424641) | Genmab | 2020-07-15 |
| Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy (NCT02205398) | Novartis Pharmaceuticals | 2014-07-28 |
Track Squamous Cell Carcinoma of Head and Neck (SCCHN) automatically
Every clearance here is in the API, with alerts when new ones post.